Patents by Inventor Matthias Eberl

Matthias Eberl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INACTIVATION OF GENES OF THE MEP PATHWAY
    Publication number: 20110129883
    Abstract: The invention relates to cells and organisms as well as to methods for producing said cells and organisms, according to which intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis (MEP pathway) are enriched by deleting or inactivating genes. The derivatives can also be enriched by using enzyme inhibitors. The enriched intermediates may be used as substrates in enzyme activity tests. The inventive cells and organisms and the enriched intermediates can further be used in the production of medicaments.
    Type: Application
    Filed: January 18, 2011
    Publication date: June 2, 2011
    Applicant: BIOAGENCY AG
    Inventors: HASSAN JOMAA, MATTHIAS EBERL, BORAN ALTINCICEK
  • Organophosphorous Compounds for the Activation of Gamma/Delta T Cells
    Publication number: 20110112054
    Abstract: The present invention describes organophosphorus compounds of general formula (I) their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
    Type: Application
    Filed: January 17, 2011
    Publication date: May 12, 2011
    Applicant: BIOAGENCY AG
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek, Martin Hintz, Oliver Wolf, Ann-Kristin Kollas, Armin Reichenberg, Jochen Wiesner
  • Inactivation of genes of the MEP pathway
    Patent number: 7875279
    Abstract: The invention relates to cells and organisms as well as to methods for producing said cells and organisms, according to which intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis (MEP pathway) are enriched by deleting or inactivating genes. The derivatives can also be enriched by using enzyme inhibitors. The enriched intermediates may be used as substrates in enzyme activity tests. The inventive cells and organisms and the enriched intermediates can further be used in the production of medicaments.
    Type: Grant
    Filed: April 13, 2002
    Date of Patent: January 25, 2011
    Assignee: Bioagency AG
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek
  • Organophosphorous Compounds for the Activation of Gamma/Delta T Cells
    Publication number: 20080249067
    Abstract: The present invention describes organophosphorus compounds of general formula (I) their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
    Type: Application
    Filed: June 11, 2008
    Publication date: October 9, 2008
    Applicant: Bioagency AG
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek, Martin Hintz, Oliver Wolf, Ann-Kristin Kollas, Armin Reichenberg, Jochen Wiesner
  • Inactivation Of Genes Of The Mep Pathway
    Publication number: 20080206267
    Abstract: The invention relates to cells and organisms as well as to methods for producing said cells and organisms, according to which intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis (MEP pathway) are enriched by deleting or inactivating genes. The derivatives can also be enriched by using enzyme inhibitors. The enriched intermediates may be used as substrates in enzyme activity tests. The inventive cells and organisms and the enriched intermediates can further be used in the production of medicaments.
    Type: Application
    Filed: April 13, 2002
    Publication date: August 28, 2008
    Applicant: BIOAGENCY AG
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek
  • Organo-phosphorous compounds for activating gamma/delta T cells
    Patent number: 7399756
    Abstract: The present invention describes organophosphorus compounds of general formula (I) their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: July 15, 2008
    Assignee: Bioagency AG
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek, Martin Hintz, Oliver Wolf, Ann-Kristin Kollas, Armin Reichenberg, Jochen Wiesner
  • Organo-phosphorous compounds for activating gamma/delta t cells
    Publication number: 20060030546
    Abstract: The present invention describes organophosphorus compounds of general formula (I) their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
    Type: Application
    Filed: July 18, 2002
    Publication date: February 9, 2006
    Applicant: Innate Pharma
    Inventors: Hassan Jomaa, Matthias Eberl, Boran Altincicek, Martin Hintz, Oliver Wolf, Ann-Kristin Kollas, Armin Reichenberg, Jochen Wiesner